The different combinations of the urine levels of two metalloproteinases (MMP-2 and MMP-9) and MMP-9/neutrophil gelatinase-associated lipocalin (NGAL) complex and age were evaluated in ovarian cancer compared to benign tumors. This evidence concerns the gene MMP9 and ovarian cancer.